Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer

医学 癌症 外科肿瘤学 药理学 腹部外科 曲妥珠单抗 癌症研究 肿瘤科 内科学 乳腺癌
作者
Jiankun Liu,Tengfang Zhu,Ruijing Zhao,Wenjun Ren,Fei Zhao,Paul Liu
出处
期刊:Gastric Cancer [Springer Science+Business Media]
标识
DOI:10.1007/s10120-024-01478-6
摘要

Abstract Background HER2-targeted therapies have improved the outcomes of HER2-positive gastric cancer (GC), yet resistance remains a challenge. We sought to explore the effects of reversible and irreversible HER2 tyrosine kinase inhibitors (TKIs) alone or in combination with the HER2-targeting antibody drug conjugate trastuzumab deruxtecan (T-Dxd). Methods The effects of HER2-TKIs on HER2 and downstream signaling were evaluated via Western blotting. Proteasomal inhibitors and co-immunoprecipitation assays were performed to explore the role of proteasomal degradation in HER2 expression modulation, and immunofluorescence assays were employed to explore mechanisms of HER2 internalization. The synergistic potential of the irreversible HER2-TKI pyrotinib in combination with T-Dxd was validated using growth and viability assays in anti-HER2-positive GC cell cultures and tumor growth and immunohistochemical staining assays in a mouse xenograft model. Results Our study revealed that reversible HER2-TKIs elevated HER2 protein levels, whereas irreversible HER2-TKIs decreased them. Pyrotinib triggered HER2 degradation within the proteasome by promoting ubiquitination and dissociation from HSP90. Furthermore, pyrotinib substantially induced HER2 internalization, which led to improved cellular uptake of T-Dxd. The increased T-Dxd uptake was accompanied by greater efficacy in suppressing the growth of GC cells and enhanced anti-tumor effects in an animal model. Conclusion In summary, our research reveals the molecular mechanisms of irreversible HER2-TKIs in regulating HER2 protein expression by promoting HER2 internalization. These findings advance our comprehension of targeted therapy for GC and provide a promising therapeutic combination strategy with enhanced efficacy against HER2-positive GC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
鸽子完成签到,获得积分10
刚刚
Ch完成签到,获得积分10
刚刚
ColdPomelo完成签到,获得积分10
刚刚
勋章完成签到 ,获得积分10
1秒前
科研通AI6.3的应助被辰辰采纳,获得10
1秒前
最好的支支在我身边完成签到 ,获得积分10
1秒前
布丁完成签到,获得积分10
1秒前
秀丽天德完成签到,获得积分10
2秒前
小凤姑娘完成签到,获得积分10
2秒前
往事随风发布了新的文献求助10
3秒前
ss完成签到 ,获得积分10
4秒前
奶龙完成签到 ,获得积分10
4秒前
科研完成签到 ,获得积分10
5秒前
想把太阳揣兜里完成签到,获得积分0
5秒前
陈慕枫完成签到,获得积分10
5秒前
hikiyi完成签到,获得积分10
6秒前
磊磊完成签到,获得积分10
6秒前
秒速五厘米的应助被山海不远采纳,获得10
6秒前
细腻驳完成签到,获得积分10
6秒前
6秒前
小白完成签到,获得积分10
7秒前
阿拉哈哈笑完成签到,获得积分10
7秒前
DavidChen完成签到,获得积分10
7秒前
陶醉紫夏完成签到,获得积分10
7秒前
7秒前
瘦瘦滢完成签到,获得积分10
8秒前
平淡的荆完成签到,获得积分10
8秒前
马格完成签到,获得积分10
9秒前
fengye完成签到,获得积分10
9秒前
忐忑的书桃完成签到 ,获得积分10
9秒前
阿信苏发布了新的文献求助10
10秒前
杨建航完成签到,获得积分10
10秒前
白白白完成签到,获得积分10
11秒前
yl完成签到 ,获得积分10
11秒前
徐慕源完成签到,获得积分10
11秒前
11秒前
顺心的谷菱完成签到,获得积分10
11秒前
11秒前
能帮就帮完成签到,获得积分10
12秒前
淡淡碧玉完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039